Medical cannabis and marijuana extracts should not be used for the treatment of obstructive sleep apnea, according to a statement from the American Academy of Sleep Medicine.
The trial will help distinguish between multiple formulations based on various measures, including pharmacological and pharmacodynamic measures that may be predictive of drug efficacy.
The company behind the study hopes to complete their study evaluating the use of cannabis oil for treating chronic pain by fall 2018.
Human brain imaging clinical trials are already underway for a proprietary cannabinoid formulation to treat a major condition.
Results indicate that the cannabinoid compounds have different apoptotic - or cell-killing effects - depending on the dosage, type of cancer and the compound configuration.
This topic has been debated by many experts and it remains contested whether a cause-and-effect relationship between smoking cannabis and schizophrenia truly exists.